Last edition
News about Biotechnology
Novartis discontinues hydroxychloroquine trial for COVID-19 due to acute enrollment challenges
Novartis has made the decision to stop and discontinue its sponsored hydroxychloroquine(HCQ) clinical trial for COVID-19 due to acute enrollment challenges that have made trial completion infeasible
Biotechnology | 22/06/2020 | By Darshana | 231
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, announced the completion of its acquisition of Quantified Ag, a leading data and analytics company that monitors cattle body temperature and movement in order to detect illness early
Biotechnology | 19/06/2020 | By Darshana | 280
Neurocrine Biosciences Inc and Takeda Pharmaceutical Company Limited announced a strategic collaboration to develop and commercialise compounds in Takeda's early-to-mid-stage psychiatry pipeline. Specifically, Takeda granted an exclusive license to Neurocrine Biosciences for seven pipeline programmes, including three clinical stage assets
Biotechnology | 18/06/2020 | By Darshana | 184
Bayer announced today the initiation of the FINEARTS-HF study, a multicenter, randomized, double-blind, placebo-controlled Phase III study to evaluate the efficacy and safety of finerenone on morbidity and mortality in patients suffering from symptomatic heart failure
Biotechnology | 16/06/2020 | By Darshana | 531
Following National Pharmaceutical Pricing Authority (NPPA) directive to address the demand of tocilizumab injection in government hospitals in Gujarat for the treatment of COVID-19 patients, the Mumbai-based pharmaceutical major Cipla Ltd has renewed its supply by releasing another batch of 700 tocilizumab injections to Gujarat
Biotechnology | 11/06/2020 | By Darshana | 869
Lupin: U.S. FDA Grants Mexiletine Orphan Drug Designation
Pharma major Lupin Limited (Lupin) is announced today that the US Food and Drug Administration (U.S. FDA) has granted Orphan Drug Designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders
Biotechnology | 08/06/2020 | By Darshana | 631
FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection
Today the U.S. Food and Drug Administration took steps to further support the development of COVID-19 tests for at-home self-collection by including a voluntary EUA template for at-home sample collection kits to its website
Biotechnology | 01/06/2020 | By Darshana | 146
Today the U.S. Food and Drug Administration took a new step to support the agency's evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel. Reference panels are an additional step to ensure the quality of the tests, validation of new assays, test calibration, and monitoring of assay performance
Biotechnology | 28/05/2020 | By Darshana | 146
ICMR to present fully indigenous diagnostic platform for COVID-19
The Indian Council of Medical Research (ICMR) has validated a fully indigenous diagnostic platform for COVID-19 diagnosis.
Biotechnology | 25/05/2020 | By Darshana | 223
FDA Provides Promised Transparency for Antibody Tests
Today, the U.S. Food and Drug Administration posted a list of antibody tests that are being removed from the notification list of tests being offered under the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency
Biotechnology | 22/05/2020 | By Darshana | 135
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy